A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and ...

GSK posted higher profit as sales for its specialty treatments for HIV, cancer and asthma beat expectations, offsetting lower ...

India's first dengue vaccine, expected to launch in 2026 after local trials; WHO-approved jab offers two-dose protection ...

GSK Plc reported better-than-expected profit in the first quarter, with sales from its asthma and HIV drugs offsetting a ...

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Mar. 19, 2025 — A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine ...

GSK (GSK) stock gains as the company's Q1 2025 results beat Street forecasts thanks to its Specialty Medicines business. Read ...